Skip to main content
Clinical Trials/NL-OMON47632
NL-OMON47632
Recruiting
Not Applicable

Amsterdam/Aarhus Chronic Thromboembolic Pulmonary Hypertension / Chronic Thromboembolic Disease (CTEPH/CTED) Cohort (2A3C) Study<br> - 2A3C Study

Vrije Universiteit Medisch Centrum0 sites200 target enrollmentTBD

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Chronic Thromboembolic Pulmonary Hypertension
Sponsor
Vrije Universiteit Medisch Centrum
Enrollment
200
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • \- Diagnosis of CTEPH or CTED (according to ESC/ERS guidelines (11\))
  • \- Scheduled for evaluation to determine possibility of PEA or BPA
  • \- Age \> 18

Exclusion Criteria

  • \- Pacemaker or other metal objects in the body
  • \- Severe claustrophobia
  • \- Severe renal insufficiency (eGFR \< 30 mL/min)
  • \- Allergy to gadolinium contrast
  • \- Inability to provide informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials